Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2,6,6-tetramethyl-4-piperidone
EC Number:
212-554-2
EC Name:
2,2,6,6-tetramethyl-4-piperidone
Cas Number:
826-36-8
Molecular formula:
C9H17NO
IUPAC Name:
2,2,6,6-tetramethylpiperidin-4-one
Details on test material:
- Physical state: melt; yellow to dark yellow
- Storage condition of test material: room temperature

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Pirbright White Strain (Tif: DHP)
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Ciba-Geigy Limited, Animal Production, Switzerland
- Weight at study initiation: 327 - 425 g
- Housing: single
- Diet: standard guinea pig pellets, NAFAG No. 845, Gossau SG (ad libitum)
- Water: ad libitum
- Acclimation period: yes, not further specified

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12


Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
other: intradermal and epicutaneous, occlusive
Vehicle:
other: Oleum arachidis or vaseline
Concentration / amount:
- induction phase: intradermal: 1% (in Oleum arachidis); epicutaneous: 50% (in vaseline);
- challenge phase: 50% (in vaseline);
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: Oleum arachidis or vaseline
Concentration / amount:
- induction phase: intradermal: 1% (in Oleum arachidis); epicutaneous: 50% (in vaseline);
- challenge phase: 50% (in vaseline);
No. of animals per dose:
- test group: 10 males and 10 females;
- control group: 5 males and 5 females;
Details on study design:
RANGE FINDING TESTS:
The following concentrations of test article have been prepared for intradermal injection: 1, 3, and 5 % in Oleum arachidis. In a pretest 3 and 5% in Oleum arachidis induced skin necrosis at the injection sites. Therefore 1% in Oleum arachidis was used for intradermal induction.
The following concentrations of TK 11831 have been examined on separate animals for the determination of the maximum subirritant concentration: 1, 5, 10, 20, 30, and 50% in vaseline. Erythema reactions were observed with 30 and 50% TK 11831 in vaseline. Therefore 50% in vaseline was used for epidermal induction and challenge phase.

MAIN STUDY
A. INDUCTION EXPOSURE
First inductionweek, intradermal injection:
Three pairs of intradermal injections (0.1 ml per injection) were made simultaneously into the shaved neck of the guinea pigs as follows:
- adjuvant/saline mixture 1:1 (v/v)
- test article TK 11831 in Oleum arachidis (w/v)
- test article TK 11831 in the adjuvant/saline mixture (w/v)
Second inductionweek, epidermal application:
In the second week of induction TK 11831 was incorporated in vaseline (w/w) and applied on a filterpaper patch to the neck of the animals (patch 2x4 cm; approx. 0.4 g paste per patch; occluded administration for 48 hours).
Rest period:
During weeks 3 and 4 no treatments were performed.
- Control group: treated with adjuvant and the vehicle
- Site: neck region
- Concentrations: intradermal: 1% (in oleum arachidis); epidermal: 50% (in vaseline);


B. CHALLENGE EXPOSURE
The animals were tested on the flank with TK 11831 in vaseline (w/w) and the vehicle alone (patch 2x2 cm; approx. 0.2 g paste per patch; occluded administration for 24 hours).
- No. of exposures: 1
- Control group: treated with the vehicle as well as with the test article to check the maximum subirritant concentration of the test article in adjuvant treated animals
- Site: flank
- Concentrations: 50% in vaseline
- Evaluation (hr after challenge): 24 and 48 h after removing the dressings, the challenge reactions were graded according to the Draize scoring scale

Positive control substance(s):
yes
Remarks:
see below (positive control results)

Results and discussion

Positive control results:
The sensitivity of the strain is checked once or twice per year with a known sensitiser, such as mercaptobenzothiazole, benzocaine, or potassium-dichromate. The results of the latest positive control test are presented in this report.

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
1st reading
Hours after challenge:
24
Group:
other: challenge control (no treatment in the induction period)
Dose level:
50%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: challenge control (no treatment in the induction period). Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
other: challenge control (no treatment in the induction period)
Dose level:
50%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: challenge control (no treatment in the induction period). Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50%
No. with + reactions:
20
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 20.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50%
No. with + reactions:
18
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 18.0. Total no. in groups: 20.0.

Any other information on results incl. tables

Vehicle controls (treatment only in the induction period): 24 h after challenge: 0/20; 48 h after challenge: 0/20;

Challenge reactions of the test group after epidermal application (mean Draize score):

24 h after removal of the dressing: erythema: 1.8; edema: 0.5;

48 h after removal of the dressing: erythema: 1.2; edema: 0.3;

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information
Conclusions:
According to the test conditions, the test substance has to be classified: Xi, R43 (EU) and Cat. 1 (GHS).